Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in Stage II Colorectal Cancer

European Journal of Histochemistry

Volumn 43, Issue 4, 1999, Pages 311-316

  Clarke, G ^a   Ryan, E ^a   Crowe, J ^a   O'Keane, J C ^a   MacMathuna P ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Colorectal cancer; Micrometastases; P53; Survival

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMISTRY; COLORECTAL TUMOR; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MUTATION; PATHOLOGY; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033391942     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Adell G., Boeyrd B., Fronlund B., Sjodahl R., Hakansson L., et al.,: Occurrence and prognostic significance of micrometastases in regional lymph nodes in Duke's B colorectal carcinoma: an immunohistochemical study. Eur. J. Surg. 162(8), 637-642, 1996.
2. American Cancer Society: Facts and Figures, 1996.
3. Boring C.C., Squires T.S., and Tong T.: Cancer Statistics. CA Cancer. J. Clin. 43, 7-8, 1993.
4. Chang K., Ding I., Kern F.G., and Willingham M.C.: Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumours. J. Histochem. Cytochem. 39, 1281-87, 1991.
5. Cutait R., Alves V.A., Lopes L.C., Cutait D.E., Borges J.L., and Singer J.: Restaging of Colorectal Cancer Based on the Identification of Lymph Node Micrometastases Through Immunoperoxidase Staining of CEA and Cytokeratins. Dis. Col. & Rect. 34, 917-920, 1991.
6. Davidson B.R., Sams V.R., Styles J., Deane C., and Boulos P.B.: Detection of occult nodal metastases in patients with colorectal carcinoma. Cancer 65(4), 967-970, 1990.
7. Dobbelstein M., and Roth J.: The large T antigen of simian virus 40 binds and inactivates p53 but not p73. J. Gen. Virol. 79, 3079-83, 1998,
8. Freedman D.A, and Levine A.J.: Regulation of the p53 protein by the MDM2 oncoprotein - thirty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res. 59(1), 1-7, 1999.
9. Greenson J.K., Isenhart C.E., Rice R., Hojzisik C., Houchens D., and Martin E.W.: Identification of Occult Micrometastases in Pericolic lymph Nodes of Dukes's B Colorectal Cancer Patients using Monoclonal Antibodies against Cytokeratin and CC49. Cancer 73, 563-569, 1994.
10. Gunn J., McCall J.L., Yun K., and Wright P.A.: Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcriptase polymerase chain reaction. Lab. Invest. 75(4), 611-616, 1996.
11. Hayashi N., Arakawa H., Nagase H., Yanagisawa A., Kato Y., Ohta H., et al.: Genetic Diagnosis Identifies Occult Lymph Node Metastases undetectable by the Histopathological Method. Cancer Research 54, 3853-3856, 1994.
12. Hayashi N., Ito I., Yanagisawa A., Kato Y, Nakamori S., Imaoka S., et al.: Genetic diagnosis of lymph node metastasis in colorectal cancer. Lancet 345, 1257-1259, 1995.
13. Jen J., Kim H., Piantadosi S., Liu Z.F., Levitt R.C., Sistonen P., et al.: Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. Jul 28, 331(4), 213-21, 1994
14. Jeffers M.D., O'Dowd G.M., Mulcahy H., Stagg M., O'Donoghue D.P., and Toner M.: The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J. Pathol., 172(2), 183-187, 1994.
15. Kronborg O.: Staging and Surgery for Colorectal Cancer. Eur. J. Cancer 2, 1463-1465, 1993.
16. Lieffers G.J., Cleton-Jansen A.M., van de Velde C.J.H., Hermanns J., Van Krieken J.H.J.M., Cornelisse C.J., et al.: Micrometastases and Survival in Stage II Colorectal Cancer. N. Engl. J. Med. 339, 223-238, 1998.
17. Nicholson A.G., Marks C.G., and Cook M.G.: Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas. Gut 35(10), 1447-1448, 1994.
18. Purdie C.A., O'Grady J., Piris J., Wyllie A.H., and Bird C.C.: p53 expression in Colorectal Tumors. Am. J. Path. 138, 807-813, 1991.
19. Sun X.F., Carstensen J.M., Zhang H., Stal O., Wingren S., Hatschek T., et al.: Prognostic Significance of Cytoplasmic p-53 oncoprotein in colorectal adenocarcinoma. Lancet 340, 1369-137, 1992.